Advice
Medicine discontinued
calcium polystyrene sulphonate (Sorbisterit) has been discontinued by the manufacturer (see link).
Medicine details
- Medicine name:
- calcium polystyrene sulphonate (Sorbisterit)
- SMC ID:
- 890/13
- Indication:
For treatment of hyperkalaemia, in patients with acute and chronic renal insufficiency, including patients undergoing dialysis treatment.
- Pharmaceutical company
- Stanningly Pharma Limited
- BNF chapter
- Nutrition and blood
- Submission type
- Abbreviated
- Status
- Withdrawn
- Date advice published
- 12 August 2013
Additional notes
calcium polystyrene sulphonate (Sorbisterit) has been discontinued by the manufacturer (see link).
In line with SMC process, the SMC advice has been removed from the website.